In vitro antimicrobial activity of 3,4-dihydro-s-triazinobenzimidazole derivatives

Folia Microbiologica

Volumn 47, Issue 1, 2002, Pages 29-31

  Gulyas G ^a   Emri, T ^a   Simon, A ^a   Gyorgydeak Z ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); FUNGI;

ANTIINFECTIVE AGENT; BENZIMIDAZOLE DERIVATIVE; TRIAZINE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG EFFECT; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BENZIMIDAZOLES; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; TRIAZINES;

EID: 0036051836     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02818561     Document Type: Article

References (13)

1. ABDEL-RAHMAN R.M., SEADA M., EL-GENDY Z., ISLAM I.E., MAHMOUD M.N.: Synthesis of some new 4,6-disubstituted 1,2,4-triazin-3,5(2H)diones and related compounds of potential antifungal activity. Farmaco 48, 407-416 (1993).
2. BADAWEY E.A.M., KAPPE T.: Synthesis and in vitro anti-HIV activity of certain 2-(1H-benzimidazol-2-ylamino)pyrimidin4(3H)-ones and related derivates. Arch.Pharm.Pharm.Med.Chem. 330, 59-62 (1997).
3. FEKETE-FORGÁCS K., GYÜRE L., LENKEY B.: Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans. Mycoses 43, 273-279 (2000).
4. HOLLA B.S., SAROJINI B.K., GONSALVES R.: Synthesis of some new biologically active thiadiazolotriazinones. Farmaco 53, 395-398 (1998).
5. JANTOVÁ S., GREIF G., PAVLOVIČOVÁ R., ČIPÁK L.: Antibacterial effect of some 1-substituted 1,2,4-triazoles. Folia Microbiol. 43, 75-78 (1998).
6. JANTOVÁ S., ŠPIRKOVÁ K., STAŇKOVSKÝ S., DUCHOŇOVÁ P.: Antibacterial effect of some substituted tricyclic quinazolines and their synthetic precursors. Folia Microbiol. 43, 187-190 (1999).
7. JANTOVÁ S., GREIF G., ŠPIRKOVÁ K., STAŇKOVSKÝ S., ORAVCOVÁ M.: Antibacterial effect of trisubstituted quinazoline derivatives. Folia Microbiol. 45, 133-137 (2000).
8. MARTIN D., GRAUBAUM H., KEMPTER G., EHRLICHMANN W.: Umsetzungen von 2-Guanidino-benzimidazol mit elektrophilen Reagentien. J.Prakt.Chem. 323, 303-310 (1981).
9. NESM̌RÁK K., PELOUCHOVÁ H., VŠETEČKA V., NĚMEC I., GABRIEL J.: Antifungal effects of new heterocyclic compounds, 6H-pyrimido[2,1-a]isoindole derivatives. Folia Microbiol. 43, 39-43 (1998).
10. PÓCSI I., SÁMI L., LEITER É., MAJOROS L., SZABÓ B., EMRI T., PUSZTAHELYI T.: Searching for new-type antifungal drugs. Acta Microbiol.Immunol.Hung. 48, 533-543 (2001).
11. SERAFIN B., BORKOWSKA G., GLOWCZYK J., KOVALSKA Y., RUMP S.: Potential antihypertensive benzimidazole derivates. Polon.J.Pharmacol.Pharm. 41, 89-96 (1989).
12. STRIGÁČOVÁ J., HUDECOVÁ D., VAREČKA L'., LÁSIKOVÁ A., VÉGH D.: Some biological properties of new quinoline-4-carboxylic acid and quinoline-4-carboxamide derivatives. Folia Microbiol. 45, 305-309 (2000).
13. NEU H.C.: The crisis in antibiotic resistance. Science 257, 1064-1073 (1992).